Parabilis Medicines, Inc. Common Stock (PBLS) is a publicly traded the market company. As of September 20, 2026, PBLS trades at $41.64 with a market cap of $5.16B and a P/E ratio of -17.95. PBLS moved +1.74% today. Year to date, PBLS is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $24.51 to $42.49. Analyst consensus is strong buy with an average price target of $40.67. Rallies surfaces PBLS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks PBLS insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
| Metric | Value |
|---|---|
| Price | $41.64 |
| Market Cap | $5.16B |
| P/E Ratio | -17.95 |
| EPS | $-2.32 |
| Dividend Yield | 0.00% |
| 52-Week High | $42.49 |
| 52-Week Low | $24.51 |
| Volume | 1.16M |
| Avg Volume | 0 |
| Revenue (TTM) | $148.00K |
| Net Income | $-52.46M |
| Gross Margin | 0.00% |
5 analysts cover PBLS: 0 strong buy, 5 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $40.67.